Evidence map›Paper›PMID 40687812›Full record

ReviewiScience2025

Comprehensive application of artificial intelligence in colorectal cancer: A review.

Kui Sun, Ying Wang, Ruize Qu, Qing Yang, Renjie Luo, Zhihan Jiang, Hao Wang, Wei Fu

Abstract readReview
In one paragraph

Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kui SunDepartment of General Surgery, Peking University Third Hospital, Beijing, China.
Ying WangShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Ruize QuDepartment of General Surgery, Peking University Third Hospital, Beijing, China.
Qing YangDepartment of General Surgery, Peking University Third Hospital, Beijing, China.
Renjie LuoDepartment of General Surgery, Peking University Third Hospital, Beijing, China.
Zhihan JiangDepartment of General Surgery, Peking University Third Hospital, Beijing, China.
Hao WangCancer Center, Peking University Third Hospital, Beijing, China.
Wei FuDepartment of General Surgery, Peking University Third Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is increasingly integrated into the clinical management of colorectal cancer (CRC), playing a role in areas ranging from disease screening and therapy assistance to daily care and prognostic assessment. While AI's capabilities are clear, several challenges, including those related to ethics, data privacy, and deployment, must be addressed to fully realize its potential in driving innovation and advancing medical technologies. In this review, we provide a comprehensive summary of AI's applications in the clinical management of CRC, examine the areas in which it has been incorporated, and discuss the limitations and key considerations that will guide future research. Looking ahead, we believe AI's role in CRC management will only deepen, with the potential to contribute to personalized, overall clinical care and reshape the future of medicine.

Indexed as

artificial intelligence applicationsoncology

Identifiers

PMID40687812
PMCPMC12272945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.